今日上海
外高桥生物医药产业园揭牌 - 2020年12月04日
Industrial park, R&D center inaugurated in FTZ bonded area
The Shanghai Waigaoqiao Bio-medicine Industrial Park and the BeiGene Shanghai Research & Development Center were recently inaugurated in the Shanghai Free Trade Bonded Area.
Agreements on nine biomedicine industrial projects, including BeiGene Shanghai Research & Development Center, BeiGene-Artemed Hospital and a Hillhouse Medical Instruments project, were signed at the inauguration ceremony.
Meanwhile, the Shanghai Free Trade Zone administration signed contracts with Hillhouse Capital to jointly allocate resources for enterprises and establish a biomedicine ecosystem.
The BeiGene Research Center has set up over 4,000 square meters of standardized laboratories specializing in macromolecular antibody drugs.